Bi-213-anti-EGFR-cetuximab (Technical University of Munich)

N/A

Report date: 2025/11/24 17:58:29

Base Information

Drug NameBi-213-anti-EGFR-cetuximab (Technical University of Munich)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnosticsRadiation-emitting products > Radioactive diagnostic agent +[7]

Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists

TargetsEpidermal growth factor receptor erbB1

Therapy Area/IndicationsDiagnostic agents

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesTechnical University Of Munich

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTechnical University Of Munich

Active IndicationsN/A

Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A